All Releases

Aug 03, 2023
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
Pivotal Study of NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population LATHAM, N.Y. --(BUSINESS WIRE)--Aug. 3, 2023-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the
Jul 24, 2023
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
LATHAM, N.Y. --(BUSINESS WIRE)--Jul. 24, 2023-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today
Apr 11, 2023
AngioDynamics to Present at the Needham Virtual Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Apr. 11, 2023-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today
Feb 28, 2023
AngioDynamics to Participate in Three Investor Conferences in March
LATHAM, N.Y. --(BUSINESS WIRE)--Feb. 28, 2023-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today
Dec 20, 2022
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Dec. 20, 2022-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today
Nov 17, 2022
AngioDynamics to Present at the Piper Sandler Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Nov. 17, 2022-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today
Oct 31, 2022
AngioDynamics , The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients with PE LATHAM, N.Y. --(BUSINESS WIRE)--Oct. 31, 2022-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused
Aug 03, 2022
AngioDynamics to Present at the Canaccord Genuity Growth Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Aug. 3, 2022-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today